Use of serum biomarkers to predict the development and severity of osteochondrosis lesions in the distal portion of the femur in pigs

American Journal of Veterinary Research

Volumn 71, Issue 8, 2010, Pages 946-952

  Frantz, Nolan Z ^a   Friesen, Kim G ^a   Andrews, Gordon A ^b   Tokach, Michael D ^b   Yamka, Ryan M ^a   Loughin, Tom L ^b   Nelssen, Jim L ^b   Dritz, Steve S ^b  

^a Hill's Pet Nutrition Inc   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE 2; PYRIDINOLINE; ALKALINE PHOSPHATASE; COLLAGEN;

ARTICLE; ARTICULAR CARTILAGE; BLOOD LEVEL; BONE GROWTH; BONE METABOLISM; CARTILAGE MATRIX; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FEMUR; GROWTH PLATE; HERD; LINEAR REGRESSION ANALYSIS; NONHUMAN; OSTEOCHONDROSIS; SERUM; SLAUGHTERHOUSE; SWINE; ANIMAL; ANIMAL DISEASE; BLOOD; BONE DEVELOPMENT; CARTILAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITALIZATION; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SWINE DISEASE;

ANIMALIA; SUIDAE;

ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BONE DEVELOPMENT; CARTILAGE; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR; OSTEOCHONDROSIS; SEVERITY OF ILLNESS INDEX; SWINE; SWINE DISEASES;

EID: 77956831694     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.8.946     Document Type: Article

References (53)

1. Ekman S, Carlson CS. The pathology of osteochondrosis. Vet Clin North Am Small Anim Pract 1998;28:17-32.
2. Carlson CS. Normal cartilage development and the pathogenesis of osteochondrosis, in Proceedings. 2003 Allen D Leman Swine Conf 2003;34:180-181.
3. Serenius T, Stalder KJ. Selection for sow longevity. J Anim Sci 2006;84(suppl E):E166-E171.
4. Rodriguez-Zas SL, Southey BR, Knox RV, et al. Bioeconomic evaluation of sow longevity and profitability. J Anim Sci 2003;81:2915-2922.
5. Kadarmideen HN, Schworer D, Ilahi H, et al. Genetics of osteochondral disease and its relationship with meat quality and quantity, growth, and feed conversion traits in pigs. J Anim Sci 2004;82:3118-3127. (Pubitemid 39431700)
6. Jorgensen B, Andersen L. Genetic parameters for osteochondrosis in Danish landrace and Yorkshire boars and correlations with leg weakness and production traits. Anim Sci 2000;71:427-434.
7. Ytrehus B, Grindflek E, Teige J, et al. The effect of parentage on the prevalence, severity, and location of lesions of osteochondrosis in swine. J Vet Med A Physiol Pathol Clin Med 2004;51:188-195.
8. Goedegebuure SA, Hani HJ, van der Valk PC, et al. Osteochondrosis in six breeds of slaughter pigs. I. A morphological investigation of the status of osteochondrosis in relation to breed and level of feeding. Vet Q 1980;2:28-41.
9. Carlson CS, Hilley HD, Meuten DJ, et al. Effect of reduced growth rate on the prevalence and severity of osteochondrosis in gilts. Am J Vet Res 1988;49:396-402.
10. Nakano T, Aherne FX. Involvement of trauma in the pathogenesis of osteochondritis dissecans in swine. Can J Vet Res 1988;52:154-155.
11. Reiland S. Effects of vitamin D and A, calcium, phosphorus, and protein on frequency and severity of osteochondrosis in pigs. Acta Radiol Suppl 1978;(358):91-105. (Pubitemid 9142215)
12. Nakano T, Aherne FX, Thompson JR. Effect of dietary supplementation of vitamin C on pig performance and the incidence of osteochondrosis in elbow and stifle joints in young growing swine. Can J Anim Sci 1983;63:421-428.
13. Woodard JC, Becker HN, Poulos PW Jr. Effect of diet on longitudinal bone growth and osteochondrosis in swine. Vet Pathol 1987;24:109-117.
14. Kadarmideen HN, Janss LLG. Evidence of a major gene from Bayesian segregation analysis of liability to osteochondral diseases in pigs. Genetics 2005;171:1195-1206.
15. Thonar EJMA, Lenz ME, Masuda K, et al. Body fluid markers of cartilage metabolism. In: Seibel MJ, Robins SP, Bilezikian JP, eds. Dynamics of bone and cartilage metabolism. San Diego: Academic Press Inc, 1999;453-464.
16. Fox DB, Cook JL. Synovial fluid markers of osteoarthritis in dogs. J Am Vet Med Assoc 2001;219:756-761.
17. Bhatnagar R, Christian RG, Nakano T, et al. Age related changes and osteochondrosis in swine articular and epiphyseal cartilage: light and electron microscopy. Can J Comp Med 1981;45:188-195.
18. Nakano T, Thompson JR, Aherne FX. Cartilage proteoglycans from normal and osteochondrotic porcine joints. Can J Comp Med 1985;49:219-226.
19. Wardale RJ, Duance VC. Characterization of articular and growth plate cartilage collagens in porcine osteochondrosis. J Cell Sci 1994;107:47-59. (Pubitemid 24039033)
20. Garnero P, Rousseau J, Delmas PD. Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 2000;43:953-968.
21. Garnero P, Piperno M, Gineyts E, et al. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001;60:619-626.
22. Ofluoglu D, Ofluoglu O. Assessment of disease activity and progression of osteoarthritis with using molecular markers of cartilage and synovium turnover. Curr Rheumatol Rev 2005;1:29-32.
23. Chu Q, Lopez M, Hayashi K, et al. Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage 2002;10:662-669. (Pubitemid 34993953)
24. Hegemann N, Kohn B, Brunnberg L, et al. Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. Osteoarthritis Cartilage 2002;10:714-721.
25. Frisbie DD, Ray CS, Ionescu M, et al. Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses. Am J Vet Res 1999;60:306-309.
26. Billinghurst RC, Brama PAJ, van Weeren PR, et al. Evaluation of serum concentrations of biomarkers of skeletal metabolism and results of radiography as indicators of severity of osteochondrosis in foals. Am J Vet Res 2004;65:143-150.
27. Laverty S, Ionescu M, Marcoux M, et al. Alterations in cartilage type-II procollagen and aggrecan contents in synovial fluid in equine osteochondrosis. J Orthop Res 2000;18:399-405. (Pubitemid 30599615)
28. Weiler U, Finsler S, Wehr U, et al. Comparison of blood markers for the longitudinal monitoring of osteoclastic activity in the pig. J Vet Med A Physiol Pathol Clin Med 2001;48:609-618.
29. Carter SD, Cromwell GL, Combs TR, et al. The determination of serum concentrations of osteocalcin in growing pigs and its relationship to end-measures of bone mineralization. J Anim Sci 1996;74:2719-2729.
30. Shaw DT, Rozeboom DW, Hill GW, et al. Impact of supplement withdrawal and wheat middling inclusion on bone metabolism, bone strength, and the incidence of bone fractures occurring at slaughter in pigs. J Anim Sci 2006;84:1138-1146.
31. 3. Vet Res 2002;33:383-396.
32. Carroll RJ, Ruppert D. The transform-both-sides methodology. In: Cox DR, Hinkley DV, Rubin D, et al, eds. Transformation and weighting in regression. New York: Chapman & Hall, 1988;115-160.
33. Stern S, Lundeheim N, Johansson K, et al. Osteochondrosis and leg weakness in pigs selected for lean tissue growth rate. Livest Prod Sci 1995;44:45-52.
34. Nelson F, Dahlberg L, Laverty S, et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 1998;102:2115-2125.
35. Kojima T, Mwale F, Yasuda T, et al. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis. Arthritis Rheum 2001;44:120-127. (Pubitemid 32113126)
36. Mullan RH, Matthews C, Bresnihan B. Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy. Arthritis Rheum 2007;56:2919-2928.
37. Oesser S, Seifert J. Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagen. Cell Tissue Res 2003;311:393-399. (Pubitemid 36459678)
38. Månsson B, Carey D, Alini M, et al. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 1995;95:1071-1077.
39. Manicourt DH, El Hajjaji H, Devogelaer J, et al. Products of cartilage metabolism. In: Seibel MJ, Robins SP, Bilezikian JP, eds. Dynamics of bone and cartilage metabolism. San Diego: Academic Press Inc, 1999;301-317.
40. Poole AR, Ionescu M, Swan A, et al. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan: implications for pathogenesis. J Clin Invest 1994;94:25-33. (Pubitemid 24983260)
41. Lohmander LS, Ionescu M, Jugessur H, et al. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum 1999;42:534-544.
42. Clark AG, Jordan JM, Vilim V, et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity. Arthritis Rheum 1999;42:2356-2364.
43. Vilim V, Olejarova M, Machacek S, et al. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 2002;10:707-713.
44. Hunter DJ, Li J, LaValley M, et al. Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study. Arthritis Res Ther [serial online]. 2007;9:R108. Available at: arthritis-research.com/content/9/5/R108. Accessed April 20, 2010.
45. Lindqvist E, Eberhardt K, Bendtzen K, et al. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005;64:196-201. (Pubitemid 40193611)
46. Kollerup G, Hansen M, Horslev-Peterson K. Urinary hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis: relation to disease activity and effects of methylprednisolone. Br J Rheumatol 1994;33:816-820.
47. Conrozier T, Poole AR, Ferrand F, et al. Serum concentrations of type II collagen biomarkers (C2C, C1, 2C, and CPII) suggest different pathologies in patients with hip osteoarthritis. Clin Exp Rheumatol 2008;26:430-435.
48. Trumble TN, Scarbrough AB, Brown MP. Osteochondral injury increases type II collagen degradation products (C2C) in synovial fluid of Thoroughbred racehorses. Osteoarthritis Cartilage 2009;17:371-374.
49. Lohmander LS, Atley LM, Pietka TA, et al. The release of cross-linked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 2003;48:3130-3139.
50. Garnero P, Gineyts E, Christgau S, et al. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Arthritis Rheum 2002;46:21-30. (Pubitemid 34121647)
51. Reijman M, Hazes JMW, Bierma-Zeinstra SMA, et al. A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum 2004;50:2471-2478.
52. Fuller CJ, Barr AR, Sharif M, et al. Cross-sectional evaluation comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthritis Cartilage 2001;9:49-55. (Pubitemid 32154917)
53. Allen MJ. Biochemical markers of bone metabolism in animals: uses and limitations. Vet Clin Pathol 2003;32:101-113.